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of the patients had severe or moderate VP-PM which was associated with an increased incidence of all-cause mortality that was statistically significant; however, the incidence of VP-PM associated with cardiac-related mortality was not statistically significant. In seven of these 34 studies, when both moderate and severe VP-PM were analysed separately, both moderate and severe VP-PM were associated with statistically significant increases in allcause as well as cardiac-related mortality. These apparently different findings may be explained by methodological differences. Because of methodological differences, Bailar 3 stated 'it is not uncommon to find that 2 or more meta-analyses done at the same time by investigators with the same access to the literature reach incompatible or even contradictory conclusions.' In the past, the search for a deleterious effect of VP-PM on survival has been carried out in many studies and has been intensive (the search was 'here, there, and everywhere' as it was for the Scarlet Pimpernel 4 ), but the findings have been conflicting. The review and meta-analysis by Head et al. 2 does not provide data which convincingly demonstrate that VP-PM independently resulted in increased mortality. Their problematic findings are only partly related to their own analyses but are also related to the majority of the studies that were available to them for review. These issues can be summarized as follows.
(1) The VA randomized trial 5 showed that after AVR, 60% of the adjudicated deaths were related to associated cardiac and noncardiac co-morbid conditions. A prosthetic heart valve was the cause of death in only 40%, in whom the major causes were bleeding and sudden deaths. Thus, one should be very careful about assuming that VP-PM contributed in a significant way either to all-cause or to cardiac-related mortality. Head et al. severe VP-PM. 6 An additional eight studies from the USA and Europe that were included in their review had also used the criterion of ≤0.6 cm 2 /m 2 as severe VP-PM. We too used this criterion to assess whether left ventricular outflow obstruction was severe both for aortic valve stenosis and for VP-PM. 7 -10 The universe is larger than a few highly selected centres in North America, Europe, and Asia. (3) Of the 34 cited studies, EOAi was actually measured in only eight; in 26 of 34 studies the EOAi was 'projected'. Pibarot et al. 11 showed the sensitivity and specificity of predicted EOAi in realation to measured EOAi were 73% and 80%, respectively. Bleiziffer et al. 12 carefully demonstrated that the correlation of projected EOAi with measured EOAi was very modest (r ¼ 0.62), and in their study projected EOAi had a sensitivity of 54% and specificity of 83% for predicting severe VP-PM. Florath et al. 13 demonstrated that the correlation of projected with measured EOAi was poor (r ¼ 0.49). (4) Several of the studies cited by Head et al. 2 did not include hospital/early mortality in the long-term mortality data.
(5) In all the cited studies, the cause(s) of death were not adjudicated.
The Scarlet Pimpernel used many disguises and therefore was not apprehended. 4 Similarly, VP-PM has been disguised under the cloak of all-cause and/or cardiac-related cause of death, and therefore it has been elusive. If one wants to determine successfully whether VP-PM increases mortality, then the search should be focused.
